≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Short stature starting before birth

Endpoint Browser PheWeb

E4_SHORT_STATURE_STARTING_BEFORE_BIRTH

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — E34.31
  • Hospital discharge: ICD-9 — 2594A
  • Cause of death: ICD-10 — E34.31
  • Cause of death: ICD-9 — 2594A

2 out of 7 registries used, show all original rules.

146

4. Check minimum number of events

None

146

5. Include endpoints

None

146

6. Filter based on genotype QC (FinnGen only)

124

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 124 63 61
Unadjusted period prevalence (%) 0.03 0.02 0.03
Median age at first event (years) 6.00 4.79 7.26

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
146
Matched controls
1460
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E34.31
ICD-10 Finland
Short stature, prenatal disorder
3233.8
123.9
102
*
H01AC01
ATC
somatropin; parenteral
51.2
118.3
78
32
101
Kela drug reimbursment
Anterior pituitary hypofunction
36.4
63.0
42
16
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
13.3
53.9
69
92
2594A
ICD-9 Finland
Other endocrine disorders, Dwarfism, not elsewhere classified
+∞
51.1
46
*
301
Kela drug reimbursment
Growth hormone
52.5
33.2
39
10
E34.39
ICD-10 Finland
Short stature, not elsewhere classified
13.9
31.3
32
29
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
9.3
23.0
31
41
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
21.5
21.2
31
18
E34.30
ICD-10 Finland
Short stature NOS
28.5
20.9
28
12
E34.35
ICD-10 Finland
Abnormal growth retardation
8.9
20.3
28
38
602
Kela drug reimbursment
Children's severe malnutrition
7.4
19.0
31
51
P05.1
ICD-10 Finland
Small for gestational age
18.3
17.0
26
17
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.4
15.0
50
155
Z31.5
ICD-10 Finland
Genetic counselling
5.1
14.2
35
85
E23.02
ICD-10 Finland
Neurosecretory dysfunction of the growth hormone
33.1
11.9
15
5
186
Kela drug reimbursment
Growth retardation associated with renal failure (growth hormone)
11.0
11.7
22
23
7834C
ICD-9 Finland
Symptoms concerning nutrition, metabolism and development, Lack of expected normal physiological development[HÄIRIINTYNYT PITUUSKASVU]
+∞
10.5
10
*
F82
ICD-10 Finland
Specific developmental disorder of motor function
5.1
8.1
18
39
P07.3
ICD-10 Finland
Other preterm infants
4.7
7.7
19
45
Q87.19
ICD-10 Finland
Congenital malformation syndromes predominantly associated with short stature
84.2
7.5
8
*
R62.8
ICD-10 Finland
Other lack of expected normal physiological development
10.2
7.5
14
15
P27.1
ICD-10 Finland
Bronchopulmonary dysplasia originating in the perinatal period
42.1
6.8
8
*
Z3229
NOMESCO Finland
Other healthcare associate professional
3.2
6.7
31
115
BF20A, ,
NOMESCO Finland
+∞
6.3
6
*

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
somatropin; parenteral
H01AC01 [21602690]
—
1.9e+00
1.8e+00
—
2.3e+00
3.0e+00
3.6e+00
—
—
cases:8.43%
controls:1.42%
cases:6.02%
controls:1.03%
—
—
cases:6.02%
controls:0.64%
cases:27.71%
controls:1.80%
cases:43.75%
controls:2.12%
—
7
11
76
766
5
8
78
769
—
5
5
78
772
23
14
60
762
35
16
45
737
Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
29775-4 [3014326]
1.1e+00
1.8e+00
—
—
—
3.2e+00
2.6e+00
cases:6.58%
controls:2.23%
cases:13.25%
controls:2.45%
—
—
—
—
—
—
cases:25.30%
controls:1.29%
cases:33.75%
controls:3.59%
5
16
71
700
11
19
72
758
—
—
—
21
10
62
766
27
27
53
726
Measurement of bone age from hand and elbow using X-ray
NK6MA [2001308495]
1.3e+00
1.8e+00
—
1.0e+50
—
2.6e+00
2.9e+00
cases:13.16%
controls:3.91%
cases:10.84%
controls:1.93%
—
—
cases:7.23%
controls:0.00%
—
—
cases:8.43%
controls:0.64%
cases:17.50%
controls:1.20%
10
28
66
688
9
15
74
762
—
6
0
77
777
—
7
5
76
771
14
9
66
744
Pediatric Endocrinology
OMOP4822030 [45756809]
9.3e-01
6.1e-01
—
—
2.5e+00
2.4e+00
2.2e+00
cases:11.84%
controls:5.03%
cases:8.43%
controls:4.76%
—
—
—
—
cases:10.84%
controls:1.03%
cases:32.53%
controls:4.38%
cases:42.50%
controls:7.44%
9
36
67
680
7
37
76
740
—
—
9
8
74
769
27
34
56
742
34
56
46
697
Supplier / Service Provider
OMOP5117446 [33004]
—
-4.5e-01
—
—
—
2.3e+00
2.2e+00
—
—
cases:8.43%
controls:12.61%
—
—
—
—
—
—
cases:7.23%
controls:0.77%
cases:17.50%
controls:2.39%
—
7
98
76
679
—
—
—
6
6
77
770
14
18
66
735
Isolated deficiency of growth hormone
E23.01 [2000501469]
—
—
—
1.0e+50
—
—
3.2e+00
—
—
—
—
—
—
cases:6.02%
controls:0.00%
—
—
—
—
cases:21.25%
controls:1.06%
—
—
—
5
0
78
777
—
—
17
8
63
745
Case Management Agency
251B00000X [38004193]
-3.7e-01
-1.4e-03
-3.7e-01
3.0e+00
6.2e-01
3.9e-01
1.7e-01
cases:43.42%
controls:52.65%
cases:45.78%
controls:45.82%
cases:16.87%
controls:22.65%
cases:15.66%
controls:0.90%
cases:30.12%
controls:18.79%
cases:57.83%
controls:48.20%
cases:60.00%
controls:55.91%
33
377
43
339
38
356
45
421
14
176
69
601
13
7
70
770
25
146
58
631
48
374
35
402
48
421
32
332
Hemoglobin A1c/Hemoglobin.total in Blood
4548-4 [3004410]
7.5e-01
—
—
—
—
1.5e+00
1.4e+00
cases:6.58%
controls:3.21%
—
—
—
—
—
—
—
—
cases:13.25%
controls:3.22%
cases:27.50%
controls:8.63%
5
23
71
693
—
—
—
—
11
25
72
751
22
65
58
688
Inpatient Visit
IP [9201]
6.5e-02
7.3e-01
-1.0e+50
—
2.6e+00
1.1e-01
-2.4e-01
cases:17.11%
controls:16.20%
cases:10.84%
controls:5.53%
cases:0.00%
controls:0.64%
—
—
cases:8.43%
controls:0.64%
cases:6.02%
controls:5.41%
cases:6.25%
controls:7.84%
13
116
63
600
9
43
74
734
0
5
83
772
—
7
5
76
772
5
42
78
734
5
59
75
694
Hypopituitarism
E23.0 [45561963]
—
—
—
—
—
1.0e+50
2.6e+00
—
—
—
—
—
—
—
—
—
—
cases:9.64%
controls:0.00%
cases:13.75%
controls:1.20%
—
—
—
—
—
8
0
75
776
11
9
69
744
Delayed milestone
R62.0 [45597195]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:7.50%
controls:0.66%
—
—
—
—
—
—
6
5
74
748
Disturbance of activity and attention
F90.0 [45542870]
1.8e+00
2.5e+00
—
—
—
1.9e+00
1.2e+00
cases:6.58%
controls:1.12%
cases:7.23%
controls:0.64%
—
—
—
—
—
—
cases:7.23%
controls:1.16%
cases:12.50%
controls:3.98%
5
8
71
708
6
5
77
772
—
—
—
6
9
77
767
10
30
70
723
Counselling and guidance which enhance independent living
R2130 [2001310196]
4.1e-01
—
—
—
—
2.5e+00
1.6e+00
cases:6.58%
controls:4.47%
—
—
—
—
—
—
—
—
cases:12.05%
controls:1.16%
cases:8.75%
controls:1.86%
5
32
71
684
—
—
—
—
10
9
73
767
7
14
73
739
Laboratory Visit
OMOP4822461 [32036]
-3.4e-01
6.9e-02
2.3e-01
2.2e+00
3.9e-01
3.3e-01
1.4e-01
cases:22.37%
controls:28.91%
cases:31.33%
controls:29.86%
cases:13.25%
controls:10.81%
cases:9.64%
controls:1.16%
cases:10.84%
controls:7.59%
cases:33.73%
controls:26.80%
cases:43.75%
controls:40.37%
17
207
59
509
26
232
57
545
11
84
72
693
8
9
75
768
9
59
74
718
28
208
55
568
35
304
45
449
Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]
4.2e-01
1.1e+00
—
1.0e+50
—
8.7e-01
9.6e-01
cases:11.84%
controls:8.10%
cases:18.07%
controls:6.56%
—
—
cases:6.02%
controls:0.00%
—
—
cases:12.05%
controls:5.41%
cases:32.50%
controls:15.54%
9
58
67
658
15
51
68
726
—
5
0
78
777
—
10
42
73
734
26
117
54
636
Children's severe malnutrition
602 [2001600367]
2.1e+00
—
—
—
—
—
—
cases:9.21%
controls:1.26%
—
—
—
—
—
—
—
—
—
—
—
—
7
9
69
707
—
—
—
—
—
—
Specific developmental disorder of motor function
F82 [45605516]
1.8e+00
—
—
—
—
—
2.1e+00
cases:6.58%
controls:1.12%
—
—
—
—
—
—
—
—
—
—
cases:8.75%
controls:1.20%
5
8
71
708
—
—
—
—
—
7
9
73
744
Pediatric Medicine
37 [38004477]
-5.1e-03
4.8e-01
-7.3e-02
—
1.5e+00
5.9e-01
4.5e-01
cases:56.58%
controls:56.70%
cases:46.99%
controls:35.52%
cases:9.64%
controls:10.30%
—
—
cases:28.92%
controls:8.37%
cases:48.19%
controls:34.02%
cases:56.25%
controls:45.02%
43
406
33
310
39
276
44
501
8
80
75
697
—
24
65
59
712
40
264
43
512
45
339
35
414
Tissue transglutaminase IgA Ab [Units/volume] in Serum
31017-7 [3019050]
6.8e-02
1.3e+00
—
1.0e+50
—
—
5.6e-01
cases:9.21%
controls:8.66%
cases:15.66%
controls:4.76%
—
—
cases:6.02%
controls:0.00%
—
—
—
—
cases:15.00%
controls:9.16%
7
62
69
654
13
37
70
740
—
5
0
78
777
—
—
12
69
68
684
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
5.1e-01
1.2e+00
—
—
-1.0e+50
3.9e-01
2.1e-01
cases:10.53%
controls:6.56%
cases:18.07%
controls:6.31%
—
—
—
—
cases:0.00%
controls:2.06%
cases:7.23%
controls:5.03%
cases:12.50%
controls:10.36%
8
47
68
669
15
49
68
728
—
—
0
16
83
761
6
39
77
737
10
78
70
675
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
2.1e-01
9.7e-01
—
1.0e+50
—
8.4e-01
9.0e-01
cases:11.84%
controls:9.78%
cases:18.07%
controls:7.72%
—
—
cases:6.02%
controls:0.00%
—
—
cases:13.25%
controls:6.19%
cases:32.50%
controls:16.33%
9
70
67
646
15
60
68
717
—
5
0
78
777
—
11
48
72
728
26
123
54
630
cefuroxime; oral, parenteral
J01DC02 [21602884]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.77%
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.46%
—
0
6
83
771
—
—
—
—
0
11
80
742
Orchitis, epididymitis and epididymo-orchitis without abscess
N45.9 [45548671]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
5
80
748
Oral health check
SAB03 [2001310281]
-1.4e-01
-5.3e-02
—
—
—
3.3e-01
3.3e-01
cases:10.53%
controls:11.87%
cases:7.23%
controls:7.59%
—
—
—
—
—
—
cases:8.43%
controls:6.19%
cases:26.25%
controls:20.32%
8
85
68
631
6
59
77
718
—
—
—
7
48
76
728
21
153
59
600
hydrocortisone butyrate
D07AB02 [21602106]
-1.7e-01
—
—
—
—
—
1.5e-01
cases:9.21%
controls:10.75%
—
—
—
—
—
—
—
—
—
—
cases:11.25%
controls:9.83%
7
77
69
639
—
—
—
—
—
9
74
71
679
Operation on frenulum of tongue
EJC20 [2001302185]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
76
711
—
—
—
—
—
—
Pharmacy visit
OMOP4822462 [581458]
-1.8e-01
-1.1e-02
2.5e-01
-1.0e+50
4.0e-01
5.8e-02
1.7e-02
cases:63.16%
controls:67.32%
cases:56.63%
controls:56.89%
cases:27.71%
controls:23.04%
cases:0.00%
controls:1.29%
cases:28.92%
controls:21.49%
cases:66.27%
controls:64.95%
cases:88.75%
controls:88.58%
48
482
28
234
47
442
36
335
23
179
60
598
0
10
83
767
24
167
59
610
55
504
28
272
71
667
9
86
other antifungals for topical use - combinations; ointment
D01AE20 [21601959]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.29%
—
—
—
—
—
—
—
0
10
83
766
—
Streptococcus sp identified in Isolate by Organism specific culture
43389-6 [3042975]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.84%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
76
710
—
—
—
—
—
—
Cholesterol in HDL [Moles/volume] in Serum or Plasma
14646-4 [3023602]
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.29%
—
—
—
—
—
—
—
—
0
10
83
767
—
—
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:1.68%
cases:0.00%
controls:0.90%
—
—
—
—
—
—
cases:0.00%
controls:1.16%
—
—
0
12
76
704
0
7
83
770
—
—
—
0
9
83
767
—
Myeloperoxidase IgG Ab [Units/volume] in Serum
48404-8 [3049804]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
76
711
—
—
—
—
—
—
Acute bronchiolitis due to respiratory syncytial virus
J21.0 [45552884]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.98%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
76
709
—
—
—
—
—
—
Complement+Immunoglobulin [Units/volume] in Red Blood Cells
4533-6 [3024403]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
—
—
—
—
0
5
83
772
—
—
—
—
—
cisapride; oral, rectal
A03FA02 [21600485]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
76
711
—
—
—
—
—
—
Hand and fingers X-ray examination
ND2AA [2001307607]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.06%
—
—
—
—
—
—
0
8
80
745
imidazoles/triazoles in combination with corticosteroids
D01AC20 [21601936]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.55%
—
—
—
—
—
—
—
0
12
83
764
—
Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
46083-2 [3043362]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:1.29%
—
—
—
—
—
—
cases:0.00%
controls:0.64%
—
—
—
0
10
83
767
—
—
—
0
5
83
771
—
Short stature, not elsewhere classified
E34.3 [45533031]
—
—
—
—
—
—
1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.25%
controls:0.00%
—
—
—
—
—
—
5
0
75
753
hydrocortisone
S02BA01 [21605166]
-1.6e-01
—
—
—
—
—
1.8e-01
cases:9.21%
controls:10.61%
—
—
—
—
—
—
—
—
—
—
cases:11.25%
controls:9.56%
7
76
69
640
—
—
—
—
—
9
72
71
681
Hand Surgery
40 [38004480]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.06%
—
—
—
—
—
—
0
8
80
745
Other urethral stricture
N35.8 [45582401]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
5
80
748
antibiotics in combination with other drugs
S01AA20 [21603571]
2.3e-01
—
—
—
—
-1.0e+50
4.8e-01
cases:6.58%
controls:5.31%
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.42%
cases:7.50%
controls:4.78%
5
38
71
678
—
—
—
—
0
11
83
765
6
36
74
717
Type 1 diabetes mellitus
E10 [45576436]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:2.37%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.33%
0
17
76
699
—
—
—
—
—
0
10
80
743
Influenza virus A+B Ag [Presence] in Specimen
24015-0 [3024891]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.77%
—
—
—
—
—
—
—
0
6
83
770
—
Inhalation anesthesia
WX400 [2001310805]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.80%
—
—
—
—
—
—
0
6
80
747
Angulation, rotation or displacement osteotomy of femur
NFK30 [2001307965]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
5
80
748
Adjustment or review of hearing aid
DAX00 [2001301528]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
5
80
748
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
—
5.4e-01
-1.0e+50
—
-1.0e+50
—
—
—
—
cases:6.02%
controls:3.60%
cases:0.00%
controls:1.29%
—
—
cases:0.00%
controls:1.54%
—
—
—
—
—
5
28
78
749
0
10
83
767
—
0
12
83
765
—
—
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
—
—
—
—
-1.0e+50
—
-1.0e+50
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.90%
—
—
cases:0.00%
controls:2.52%
—
—
—
—
0
7
83
770
—
0
19
80
734
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
-5.8e-01
4.4e-01
5.4e-01
—
—
6.1e-01
4.0e-01
cases:6.58%
controls:11.17%
cases:15.66%
controls:10.68%
cases:6.02%
controls:3.60%
—
—
—
—
cases:12.05%
controls:6.96%
cases:16.25%
controls:11.55%
5
80
71
636
13
83
70
694
5
28
78
749
—
—
10
54
73
722
13
87
67
666
Small restoration
SFA00 [2001310357]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.06%
—
—
—
—
—
—
0
8
80
745
Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
546-2 [3024135]
—
—
-1.0e+50
—
—
-1.0e+50
-3.1e-01
—
—
—
—
cases:0.00%
controls:1.03%
—
—
—
—
cases:0.00%
controls:3.99%
cases:6.25%
controls:8.37%
—
—
0
8
83
769
—
—
0
31
83
745
5
63
75
690
Short stature, not elsewhere classified
E34.39 [2000501487]
1.3e+00
1.6e+00
—
—
—
1.9e+00
—
cases:7.89%
controls:2.23%
cases:7.23%
controls:1.54%
—
—
—
—
—
—
cases:7.23%
controls:1.16%
—
—
6
16
70
700
6
12
77
765
—
—
—
6
9
77
767
—
Enolase.neuron specific [Mass/volume] in Serum or Plasma
15060-7 [3028531]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.70%
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
—
—
—
0
5
76
711
0
5
83
772
—
—
—
—
—
Oral Surgery
19 [38004464]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.80%
—
—
—
—
—
—
0
6
80
747
Salmonella sp identified in Stool by Organism specific culture
20955-1 [3004716]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.90%
—
—
—
—
—
—
—
0
7
83
769
—
Leukocytes [Presence] in Urine
33052-2 [3045414]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.06%
—
—
—
—
—
—
0
8
80
745
Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
89640-7 [1175715]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:1.40%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
0
10
76
706
—
—
—
—
—
0
5
80
748
Cardiac ultrasound examination through oesophagus
FM1BE [2001303285]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.98%
cases:0.00%
controls:0.77%
—
—
—
—
—
—
—
—
—
—
0
7
76
709
0
6
83
771
—
—
—
—
—
Other specified special examinations
Z01.8 [45581003]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:1.29%
—
—
—
—
—
—
cases:0.00%
controls:0.90%
—
—
—
0
10
83
767
—
—
—
0
7
83
769
—
No disease
A97 [2002000230]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:2.06%
—
—
—
—
—
—
cases:0.00%
controls:1.29%
—
—
—
0
16
83
761
—
—
—
0
10
83
766
—
MCH [Entitic mass]
28539-5 [3035941]
-3.1e-01
1.6e-01
-3.5e-02
—
-4.4e-03
4.1e-01
3.4e-01
cases:18.42%
controls:23.60%
cases:25.30%
controls:22.39%
cases:7.23%
controls:7.46%
—
—
cases:6.02%
controls:6.05%
cases:24.10%
controls:17.40%
cases:40.00%
controls:32.14%
14
169
62
547
21
174
62
603
6
58
77
719
—
5
47
78
730
20
135
63
641
32
242
48
511
Disturbances in tooth eruption
K00.6 [45581872]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
5
80
748
Acute laryngitis
J04.0 [45533538]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.77%
—
—
—
—
—
—
—
0
6
83
770
—
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:2.92%
—
—
—
—
—
—
0
22
80
731
topiramate; oral
N03AX11 [21604433]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.84%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
76
710
—
—
—
—
—
—
Calprotectin [Mass/mass] in Stool
38445-3 [3048689]
—
—
-1.0e+50
—
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.77%
—
—
cases:0.00%
controls:0.77%
—
—
—
—
—
—
0
6
83
771
—
0
6
83
771
—
—
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.90%
—
—
—
—
—
—
—
—
0
7
83
770
—
—
Timothy IgE Ab [Units/volume] in Serum
6265-3 [3003888]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:1.29%
—
—
—
—
—
—
cases:0.00%
controls:0.77%
—
—
—
0
10
83
767
—
—
—
0
6
83
770
—
Abdominal pain/cramps general
D01 [2002000300]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.90%
—
—
—
—
—
—
—
—
cases:0.00%
controls:2.92%
—
0
7
83
770
—
—
—
—
0
22
80
731
Measurement of bone density from two or more locations with X-ray
NK6QA [2001308500]
-1.0e+50
-1.0e+50
—
—
—
—
-1.0e+50
cases:0.00%
controls:1.82%
cases:0.00%
controls:0.90%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
0
13
76
703
0
7
83
770
—
—
—
—
0
5
80
748
Tacrolimus [Mass/volume] in Blood
11253-2 [3026250]
—
—
—
—
-1.0e+50
—
-1.0e+50
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.77%
—
—
cases:0.00%
controls:1.59%
—
—
—
—
0
6
83
771
—
0
12
80
741
Other specified postsurgical states
Z98.8 [45552147]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
76
711
—
—
—
—
—
—
Allergy/allergic reaction NOS
A92 [2002000225]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
76
711
—
—
—
—
—
—
lidocaine; ointment
D04AB01 [21602020]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
5
80
748
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
—
—
—
—
-1.0e+50
—
7.9e-01
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.64%
—
—
cases:6.25%
controls:2.92%
—
—
—
—
0
5
83
772
—
5
22
75
731
Insect bite/sting
S12 [2002000977]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.98%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
76
709
—
—
—
—
—
—
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 [36031861]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.99%
—
—
—
—
—
—
0
15
80
738
Diabetes, insulin-treated
103 [2001600103]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.20%
—
0
5
83
772
—
—
—
—
0
9
80
744
Occupational therapy functional assessment compilation tool
440362002 [4234641]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
76
711
—
—
—
—
—
—
Caries of dentine
K02.1 [45548134]
—
—
—
—
—
—
5.4e-02
—
—
—
—
—
—
—
—
—
—
—
—
cases:17.50%
controls:16.73%
—
—
—
—
—
—
14
126
66
627
Bacteria identified in Urine by Culture
630-4 [3026008]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:1.67%
—
—
—
—
—
—
—
—
—
—
—
0
13
83
764
—
—
—
—
—
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
—
—
-1.0e+50
—
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.03%
—
—
cases:0.00%
controls:1.03%
—
—
—
—
—
—
0
8
83
769
—
0
8
83
769
—
—
ofloxacin
S01AE01 [43534856]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.12%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
76
708
—
—
—
—
—
—
FEV1 --post bronchodilation
20155-8 [3023550]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
76
707
—
—
—
—
—
—
Bordetella pertussis Ab [Titer] in Serum
22116-8 [3025018]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.84%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
76
710
—
—
—
—
—
—
Preventive immunization/medic
-44 [2002000115]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.93%
—
—
—
—
—
—
0
7
80
746
cough suppressants and expectorants
R05FB02 [21603442]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:1.40%
cases:0.00%
controls:0.64%
—
—
—
—
—
—
cases:0.00%
controls:0.90%
—
—
0
10
76
706
0
5
83
772
—
—
—
0
7
83
769
—
FEV1 percent change
69983-5 [42868472]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
76
707
—
—
—
—
—
—
Open wound of wrist and hand, part unspecified
S61.9 [45554740]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.80%
—
—
—
—
—
—
0
6
80
747
Trauma/injury NOS
A80 [2002000214]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
76
711
—
—
—
—
—
—
Skin texture symptom/complaint
S21 [2002000986]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:1.26%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.06%
0
9
76
707
—
—
—
—
—
0
8
80
745
Adenovirus Ag [Presence] in Stool
31711-5 [3020393]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.77%
cases:0.00%
controls:1.06%
—
—
—
—
—
0
6
83
770
0
8
80
745
Verruca simplex
B07.9 [2000500357]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:1.12%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.20%
0
8
76
708
—
—
—
—
—
0
9
80
744
chloramphenicol
D10AF03 [21602307]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.84%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
76
710
—
—
—
—
—
—
Panorama tomography of teeth and jaws or similar X-ray examination
EB1HA [2001301913]
—
-1.0e+50
—
—
—
1.0e+00
4.6e-01
—
—
cases:0.00%
controls:3.22%
—
—
—
—
—
—
cases:7.23%
controls:2.71%
cases:13.75%
controls:9.16%
—
0
25
83
752
—
—
—
6
21
77
755
11
69
69
684
pantoprazole; oral, parenteral
A02BC02 [21600097]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.06%
—
—
—
—
—
—
0
8
80
745
Abrasion/scratch/blister
S17 [2002000982]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.40%
—
—
—
—
—
—
—
—
—
—
—
—
0
10
76
706
—
—
—
—
—
—
Monocytes/Leukocytes in Blood
26485-3 [3019069]
-2.7e-01
1.5e-01
—
—
—
-2.2e-01
3.6e-01
cases:10.53%
controls:13.41%
cases:13.25%
controls:11.58%
—
—
—
—
—
—
cases:7.23%
controls:8.89%
cases:22.50%
controls:16.87%
8
96
68
620
11
90
72
687
—
—
—
6
69
77
707
18
127
62
626
Hypoglycaemia, unspecified
E16.2 [45591038]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
—
—
—
—
0
5
83
772
—
—
—
—
—
Other medical or dental certificate
WZA90 [2001310883]
—
-1.0e+50
—
—
—
-1.0e+50
2.8e-01
—
—
cases:0.00%
controls:2.06%
—
—
—
—
—
—
cases:0.00%
controls:1.42%
cases:6.25%
controls:4.78%
—
0
16
83
761
—
—
—
0
11
83
765
5
36
75
717
Congenital vesico-uretero-renal reflux
Q62.7 [45568071]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
5
80
748
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
-2.8e-01
—
-1.0e+50
—
—
—
4.4e-01
cases:6.58%
controls:8.52%
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
cases:13.75%
controls:9.30%
5
61
71
655
—
0
5
83
772
—
—
—
11
70
69
683
General anaesthesia
WX402 [2001310806]
—
—
—
—
—
—
-2.4e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.25%
controls:7.84%
—
—
—
—
—
—
5
59
75
694
encephalitis, tick borne, inactivated, whole virus
J07BA01 [21601331]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.68%
—
—
—
—
—
—
—
—
—
—
—
—
0
12
76
704
—
—
—
—
—
—
Epstein Barr virus Ab [Presence] in Serum
49178-7 [3048929]
—
—
-1.0e+50
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
—
—
—
0
5
83
772
—
—
—
—
Eye pain
F01 [2002000399]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
5
80
748
Internal Medicine
11 [38004456]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.55%
—
—
—
—
—
—
—
0
12
83
764
—
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.98%
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.16%
—
—
0
7
76
709
—
—
—
—
0
9
83
767
—
glucagon; nasal, parenteral
H04AA01 [21602778]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:1.93%
—
—
—
—
—
—
cases:0.00%
controls:3.22%
—
—
—
0
15
83
762
—
—
—
0
25
83
751
—
chlorhexidine
S03AA04 [21605193]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.29%
—
—
—
—
—
—
—
0
10
83
766
—
General anesthesia, balanced
WX408 [2001310808]
-3.8e-01
3.4e-01
—
—
—
—
5.1e-01
cases:7.89%
controls:11.17%
cases:7.23%
controls:5.28%
—
—
—
—
—
—
—
—
cases:7.50%
controls:4.65%
6
80
70
636
6
41
77
736
—
—
—
—
6
35
74
718
Acute upper respiratory infections of multiple and unspecified sites
J06 [45601116]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
76
711
—
—
—
—
—
—
Supraglottic ventilation device
WX702 [2001310818]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
76
711
—
—
—
—
—
—
Extensive health check-up at 4 years of age
SPAT1383 [2001700483]
-2.0e-01
—
—
—
—
—
—
cases:10.53%
controls:12.57%
—
—
—
—
—
—
—
—
—
—
—
—
8
90
68
626
—
—
—
—
—
—
Protein [Mass/volume] in Urine
2888-6 [3037121]
—
—
-1.0e+50
—
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.64%
—
—
cases:0.00%
controls:1.29%
—
—
—
—
—
—
0
5
83
772
—
0
10
83
767
—
—
Social worker
Z2446 [2001311559]
7.4e-01
—
—
—
—
—
—
cases:10.53%
controls:5.31%
—
—
—
—
—
—
—
—
—
—
—
—
8
38
68
678
—
—
—
—
—
—
One-surface restoration
SFA10 [2001310358]
—
—
—
—
-1.0e+50
—
3.0e-01
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.64%
—
—
cases:18.75%
controls:14.61%
—
—
—
—
0
5
83
772
—
15
110
65
643
Cathetrisation of artery
TPH07 [2001309747]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:1.54%
—
—
—
—
—
—
—
—
—
—
—
0
12
83
765
—
—
—
—
—
Basophils/Leukocytes in Blood
30180-4 [3022096]
-4.2e-01
4.5e-02
—
—
—
-2.1e-01
3.8e-01
cases:9.21%
controls:13.41%
cases:12.05%
controls:11.58%
—
—
—
—
—
—
cases:7.23%
controls:8.76%
cases:22.50%
controls:16.60%
7
96
69
620
10
90
73
687
—
—
—
6
68
77
708
18
125
62
628
Unspecified fall
W19 [45756257]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
—
—
—
—
0
5
83
772
—
—
—
—
—
Therapeutic intervention or check-up related to orthodontic treatment, restricted
SJX11 [2001310453]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.16%
—
—
—
—
—
—
—
0
9
83
767
—
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 [706163]
3.4e-01
2.2e-01
-1.0e+50
—
—
—
1.8e-01
cases:6.58%
controls:4.75%
cases:6.02%
controls:4.89%
cases:0.00%
controls:0.64%
—
—
—
—
—
—
cases:27.50%
controls:24.04%
5
34
71
682
5
38
78
739
0
5
83
772
—
—
—
22
181
58
572
Examination and observation for other specified reasons
Z04.8 [45552063]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:1.54%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.93%
0
11
76
705
—
—
—
—
—
0
7
80
746
General evaluation of the need for rehabilitation
R1100 [2001310172]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
—
—
—
—
0
5
83
772
—
—
—
—
—
Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5159-9 [3007844]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:1.29%
—
—
—
—
—
—
—
—
—
—
—
0
10
83
767
—
—
—
—
—
Assessment of need for orthodontic treatment
SJF01 [2001310449]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:1.54%
—
—
—
—
—
—
cases:0.00%
controls:1.03%
—
—
—
0
12
83
765
—
—
—
0
8
83
768
—
Upper respiratory infection acute
R74 [2002000942]
—
-1.0e+50
—
—
—
—
-6.5e-02
—
—
cases:0.00%
controls:1.80%
—
—
—
—
—
—
—
—
cases:6.25%
controls:6.64%
—
0
14
83
763
—
—
—
—
5
50
75
703
ambroxol; oral
R05CB06 [21603385]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.20%
0
5
76
711
—
—
—
—
—
0
9
80
744
Bicarbonate [Moles/volume] in Capillary blood
1961-2 [3015235]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.90%
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.73%
—
0
7
83
770
—
—
—
—
0
13
80
740
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:2.66%
—
—
—
—
—
—
0
20
80
733
Audiometric test
21727005 [4071702]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.29%
—
—
—
—
—
—
—
0
10
83
766
—
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:1.67%
—
—
—
—
—
—
cases:0.00%
controls:1.03%
—
—
—
0
13
83
764
—
—
—
0
8
83
768
—
Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
46082-4 [3046524]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:1.29%
—
—
—
—
—
—
cases:0.00%
controls:0.64%
—
—
—
0
10
83
767
—
—
—
0
5
83
771
—
methylphenidate; oral
N06BA04 [21604757]
—
—
—
—
—
—
1.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:10.00%
controls:3.05%
—
—
—
—
—
—
8
23
72
730
Aid fitting and borrowing and monitoring of use
SPAT1230 [2001700331]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.20%
—
—
—
—
—
—
0
9
80
744
Respiratory syncytial virus Ag [Presence] in Specimen
31950-9 [3001684]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
76
711
—
—
—
—
—
—
ferrous sulfate; oral
B03AA07 [21601086]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.80%
—
—
—
—
—
—
0
6
80
747
Obesity due to excess calories
E66.01 [2000501501]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.80%
—
—
—
—
—
—
0
6
80
747
Person encountering health services in unspecified circumstances
Z76.9 [45609967]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.80%
—
—
—
—
—
—
0
6
80
747
oxcarbazepine; oral
N03AF02 [21604418]
—
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
—
—
cases:0.00%
controls:1.29%
—
—
—
—
—
—
cases:0.00%
controls:1.16%
cases:0.00%
controls:1.46%
—
0
10
83
767
—
—
—
0
9
83
767
0
11
80
742
Deep bite
K07.23 [2000502769]
—
—
-1.0e+50
—
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.64%
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
0
5
83
772
—
0
5
83
772
—
—
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.84%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
76
710
—
—
—
—
—
—
Ear pain/earache
H01 [2002000475]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.68%
—
—
—
—
—
—
—
0
13
83
763
—
hydroxyethylpromethazine, combinations
R06AD55 [21603490]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:1.40%
cases:0.00%
controls:0.64%
—
—
—
—
—
—
cases:0.00%
controls:0.90%
—
—
0
10
76
706
0
5
83
772
—
—
—
0
7
83
769
—
hydrocortisone aceponate
D07AC16 [21602135]
-1.7e-01
—
—
—
—
—
1.5e-01
cases:9.21%
controls:10.75%
—
—
—
—
—
—
—
—
—
—
cases:11.25%
controls:9.83%
7
77
69
639
—
—
—
—
—
9
74
71
679
Unspecified acute lower respiratory infection
J22 [45586665]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.80%
—
—
—
—
—
—
0
6
80
747
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
3.3e-01
9.0e-01
—
—
—
2.5e-01
5.0e-01
cases:10.53%
controls:7.82%
cases:14.46%
controls:6.44%
—
—
—
—
—
—
cases:6.02%
controls:4.77%
cases:12.50%
controls:7.97%
8
56
68
660
12
50
71
727
—
—
—
5
37
78
739
10
60
70
693
Approximal wear
K03.00 [2000502665]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
76
711
—
—
—
—
—
—
dexamethasone
S02BA06 [21605168]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.84%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
76
710
—
—
—
—
—
—
Assessment of need for rehabilitation and/or rehabilitation plan
SPAT1220 [2001700321]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.06%
—
—
—
—
—
—
0
8
80
745
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
—
-2.1e-01
—
—
—
2.7e-01
3.4e-02
—
—
cases:6.02%
controls:7.34%
—
—
—
—
—
—
cases:8.43%
controls:6.57%
cases:10.00%
controls:9.69%
—
5
57
78
720
—
—
—
7
51
76
725
8
73
72
680
Orthodontic treatment/control appointment, short
SJX10 [2001310452]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:1.03%
—
—
—
—
—
—
—
—
—
—
—
0
8
83
769
—
—
—
—
—
Clinical photography of mouth and teeth
SBB00 [2001310298]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:2.09%
cases:0.00%
controls:0.90%
—
—
—
—
—
—
cases:0.00%
controls:1.03%
—
—
0
15
76
701
0
7
83
770
—
—
—
0
8
83
768
—
prednisolone; oral, parenteral
H02AB06 [21602734]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:4.19%
cases:0.00%
controls:1.54%
—
—
—
—
—
—
cases:0.00%
controls:0.90%
—
—
0
30
76
686
0
12
83
765
—
—
—
0
7
83
769
—
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
-3.8e-01
2.5e-01
—
—
—
-2.6e-01
4.1e-01
cases:10.53%
controls:14.66%
cases:14.46%
controls:11.58%
—
—
—
—
—
—
cases:7.23%
controls:9.15%
cases:23.75%
controls:17.13%
8
105
68
611
12
90
71
687
—
—
—
6
71
77
705
19
129
61
624
Personal history of certain conditions arising in the perinatal period
Z87.6 [45581084]
1.7e+00
—
—
—
—
—
—
cases:7.89%
controls:1.54%
—
—
—
—
—
—
—
—
—
—
—
—
6
11
70
705
—
—
—
—
—
—
Dental impressions
SBB10 [2001310299]
—
—
—
—
—
—
-4.1e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:7.50%
controls:10.89%
—
—
—
—
—
—
6
82
74
671
Gastro-oesophageal reflux disease without oesophagitis
K21.9 [45538509]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.06%
—
0
5
83
772
—
—
—
—
0
8
80
745
Epilepsy, unspecified
G40.9 [45562083]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.80%
—
—
—
—
—
—
0
6
80
747
Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5257-1 [3010521]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:2.23%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.64%
—
—
0
16
76
700
—
—
—
—
0
5
83
771
—
methotrexate
L01BA01 [21601423]
-1.0e+50
-1.0e+50
—
—
-1.0e+50
-1.0e+50
—
cases:0.00%
controls:1.96%
cases:0.00%
controls:1.42%
—
—
—
—
cases:0.00%
controls:0.64%
cases:0.00%
controls:1.42%
—
—
0
14
76
702
0
11
83
766
—
—
0
5
83
772
0
11
83
765
—
Physical Medicine And Rehabilitation
25 [38004468]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.80%
—
—
—
—
—
—
—
0
14
83
762
—
Otolaryngology
4 [38004449]
2.1e-01
—
—
—
—
3.6e-01
2.3e-01
cases:19.74%
controls:16.62%
—
—
—
—
—
—
—
—
cases:7.23%
controls:5.15%
cases:13.75%
controls:11.29%
15
119
61
597
—
—
—
—
6
40
77
736
11
85
69
668
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
-5.7e-01
4.1e-01
5.4e-01
—
—
6.1e-01
4.8e-01
cases:6.58%
controls:11.03%
cases:15.66%
controls:10.94%
cases:6.02%
controls:3.60%
—
—
—
—
cases:12.05%
controls:6.96%
cases:17.50%
controls:11.55%
5
79
71
637
13
85
70
692
5
28
78
749
—
—
10
54
73
722
14
87
66
666
Lactate [Moles/volume] in Capillary blood
19239-3 [3028271]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.93%
—
—
—
—
—
—
0
7
80
746
naproxen; oral, rectal
M01AE02 [21603968]
-7.9e-01
5.0e-01
-1.0e+50
—
—
1.1e-01
3.1e-01
cases:7.89%
controls:15.92%
cases:7.23%
controls:4.50%
cases:0.00%
controls:0.64%
—
—
—
—
cases:6.02%
controls:5.41%
cases:15.00%
controls:11.42%
6
114
70
602
6
35
77
742
0
5
83
772
—
—
5
42
78
734
12
86
68
667
JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
49413-8 [3032185]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.06%
—
—
—
—
—
—
0
8
80
745
Constipation, unspecified
K59.09 [2000502926]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.68%
—
—
—
—
—
—
—
—
—
—
—
—
0
12
76
704
—
—
—
—
—
—
combinations of corticosteroids
D07XB30 [21602188]
-1.1e-01
—
—
—
—
-1.0e+50
3.4e-01
cases:6.58%
controls:7.26%
—
—
—
—
—
—
—
—
cases:0.00%
controls:3.35%
cases:10.00%
controls:7.30%
5
52
71
664
—
—
—
—
0
26
83
750
8
55
72
698
Neonatal screening
60151004 [4246502]
6.5e-01
—
—
—
—
—
1.8e+00
cases:11.84%
controls:6.56%
—
—
—
—
—
—
—
—
—
—
cases:6.25%
controls:1.06%
9
47
67
669
—
—
—
—
—
5
8
75
745
Chronic asthma and similar chronic obstructive pulmonary diseases
203 [2001600201]
5.5e-01
—
—
—
—
—
—
cases:6.58%
controls:3.91%
—
—
—
—
—
—
—
—
—
—
—
—
5
28
71
688
—
—
—
—
—
—
combinations of penicillins
J01CR50 [21602867]
3.8e-02
—
—
—
—
—
6.8e-01
cases:11.84%
controls:11.45%
—
—
—
—
—
—
—
—
—
—
cases:10.00%
controls:5.31%
9
82
67
634
—
—
—
—
—
8
40
72
713
Pain localized to other parts of lower abdomen
R10.3 [45534426]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.20%
—
—
—
—
—
—
0
9
80
744
Extensive MRI examination of abdomen with high intensity magnet
JN3CG [2001305563]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
76
707
—
—
—
—
—
—
hydrocortisone buteprate
D07AB11 [21602115]
-1.7e-01
—
—
—
—
—
1.5e-01
cases:9.21%
controls:10.75%
—
—
—
—
—
—
—
—
—
—
cases:11.25%
controls:9.83%
7
77
69
639
—
—
—
—
—
9
74
71
679
Other minor procedure in surgery of ear, nose and larynx
TDW99 [2001301879]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.98%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
76
709
—
—
—
—
—
—
Psychological sympt/compl other
P29 [2002000823]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.80%
—
—
—
—
—
—
0
6
80
747
Application of soft bandage
SPAT1211 [2001700312]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
—
—
—
—
0
5
83
772
—
—
—
—
—
Procedure duration 60 to 89 minutes
ZXE11 [2001311402]
9.9e-01
—
—
—
—
—
—
cases:7.89%
controls:3.07%
—
—
—
—
—
—
—
—
—
—
—
—
6
22
70
694
—
—
—
—
—
—
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.77%
—
—
—
—
—
—
—
—
0
6
83
771
—
—
fusidic acid
S01AA13 [21603564]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.33%
—
—
—
—
—
—
0
10
80
743
Differential panel, method unspecified - Blood
69738-3 [42870588]
-1.7e-01
1.4e-01
—
—
—
-9.1e-02
3.4e-01
cases:6.58%
controls:7.68%
cases:10.84%
controls:9.52%
—
—
—
—
—
—
cases:7.23%
controls:7.86%
cases:21.25%
controls:16.07%
5
55
71
661
9
74
74
703
—
—
—
6
61
77
715
17
121
63
632
Change in faeces/bowel movements
D18 [2002000317]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
5
80
748
Fall on same level involving ice and snow
W00 [45756242]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
5
80
748
Allergic rhinitis, unspecified
J30.4 [45548110]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
76
711
—
—
—
—
—
—
Celiac disease serology panel - Serum
94494-2 [36660697]
—
—
—
—
—
—
1.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:11.25%
controls:3.59%
—
—
—
—
—
—
9
27
71
726
Asthma, unspecified
J45.9 [45562456]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:1.29%
—
—
—
—
—
—
—
—
—
—
—
0
10
83
767
—
—
—
—
—
fluticasone furoate; nasal
R01AD12 [21605053]
—
—
—
—
-1.0e+50
5.7e-01
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.77%
cases:6.02%
controls:3.48%
—
—
—
—
—
—
0
6
83
771
5
27
78
749
—
Parainfluenza type 3 nucleic acid detection
222361000000104 [44790049]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.77%
—
—
—
—
—
—
—
—
—
—
—
0
6
83
771
—
—
—
—
—
ursodeoxycholic acid; oral
A05AA02 [21600513]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.90%
cases:0.00%
controls:1.20%
—
—
—
—
—
0
7
83
769
0
9
80
744
Sprain and strain of ankle
S93.4 [45550848]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
76
707
—
—
—
—
—
—
Oxygen saturation in Capillary blood
2709-4 [3021901]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.33%
—
0
5
83
772
—
—
—
—
0
10
80
743
Other specified counselling
Z71.8 [45581061]
—
—
—
—
—
—
-2.1e-02
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.25%
controls:6.37%
—
—
—
—
—
—
5
48
75
705
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.59%
—
0
5
83
772
—
—
—
—
0
12
80
741
hepatitis vaccines - combinations
J07BC20 [21601340]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.80%
—
—
—
—
—
—
0
6
80
747
C reactive protein [Mass/volume] in Capillary blood
48421-2 [3051387]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.84%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.93%
0
6
76
710
—
—
—
—
—
0
7
80
746
insulin aspart; parenteral
A10AD05 [21600733]
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
—
0
5
83
772
—
—
Ultrasound examination transplanted kidney
KA2AE [2001305644]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.84%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
76
710
—
—
—
—
—
—
Another gingival hyperplasia
K06.18 [2000502738]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.80%
—
—
—
—
—
—
0
6
80
747
Examination of vision
SPAT1016 [2001700117]
2.2e-01
-1.0e+50
-1.0e+50
—
—
-1.0e+50
-1.0e+50
cases:7.89%
controls:6.42%
cases:0.00%
controls:2.57%
cases:0.00%
controls:0.64%
—
—
—
—
cases:0.00%
controls:1.68%
cases:0.00%
controls:1.59%
6
46
70
670
0
20
83
757
0
5
83
772
—
—
0
13
83
763
0
12
80
741
Nutritional therapy
R4190 [2001310243]
—
—
-1.0e+50
—
-1.0e+50
6.5e-01
5.4e-01
—
—
—
—
cases:0.00%
controls:0.64%
—
—
cases:0.00%
controls:0.77%
cases:6.02%
controls:3.22%
cases:7.50%
controls:4.52%
—
—
0
5
83
772
—
0
6
83
771
5
25
78
751
6
34
74
719
Upper gastrointestinal surgery
106 [44777669]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
76
711
—
—
—
—
—
—
Extraction of tooth
EBA00 [2001301923]
—
—
—
—
—
—
2.4e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:11.25%
controls:9.03%
—
—
—
—
—
—
9
68
71
685
Specific gravity of Urine by Test strip
5811-5 [3000330]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
5
80
748
Hemoglobin [Mass/volume] in Capillary blood
30352-9 [3006184]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.80%
—
—
—
—
—
—
0
6
80
747
Bacteria [Presence] in Urine
87829-8 [36304419]
-2.8e-01
—
—
—
—
—
-3.1e-01
cases:6.58%
controls:8.52%
—
—
—
—
—
—
—
—
—
—
cases:6.25%
controls:8.37%
5
61
71
655
—
—
—
—
—
5
63
75
690
Monitored bed care
WX892 [2001310850]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:1.54%
—
—
—
—
—
—
—
—
—
—
—
0
12
83
765
—
—
—
—
—
hydrocortisone
A07EA02 [21600654]
-1.7e-01
—
—
—
—
—
1.5e-01
cases:9.21%
controls:10.75%
—
—
—
—
—
—
—
—
—
—
cases:11.25%
controls:9.83%
7
77
69
639
—
—
—
—
—
9
74
71
679
Other investigative procedure of eye
XCW99 [2001301491]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.77%
—
—
0
5
76
711
—
—
—
—
0
6
83
770
—
Suppurative and unspecified otitis media
H66 [45538332]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
5
80
748
Soybean IgE Ab [Units/volume] in Serum
6248-9 [3015076]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.80%
—
—
—
—
—
—
0
6
80
747
Open wound of other parts of foot
S91.3 [45599027]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
5
80
748
Extensive health check-up on first grade
SPAT1384 [2001700484]
—
—
-1.0e+50
—
—
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.90%
—
—
—
—
cases:0.00%
controls:2.19%
—
—
—
—
0
7
83
770
—
—
0
17
83
759
—
Cholesterol in LDL [Moles/volume] in Serum or Plasma
22748-8 [3001308]
—
—
-1.0e+50
—
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.64%
—
—
cases:0.00%
controls:1.29%
—
—
—
—
—
—
0
5
83
772
—
0
10
83
767
—
—
Scheduled procedure
ZXD10 [2001311387]
4.0e-02
6.2e-01
—
—
-1.0e+50
7.9e-01
—
cases:13.16%
controls:12.71%
cases:9.64%
controls:5.41%
—
—
—
—
cases:0.00%
controls:0.90%
cases:6.02%
controls:2.84%
—
—
10
91
66
625
8
42
75
735
—
—
0
7
83
770
5
22
78
754
—
Fracture of thumb
S62.5 [45598289]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
5
80
748
ethylmorphine; oral
R05DA01 [21603397]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
76
711
—
—
—
—
—
—
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
5
80
748
Emergency visit or other similar visit involving procedures
WYA05 [2001310871]
4.8e-01
-1.0e+50
—
—
—
-1.0e+50
—
cases:6.58%
controls:4.19%
cases:0.00%
controls:1.16%
—
—
—
—
—
—
cases:0.00%
controls:0.77%
—
—
5
30
71
686
0
9
83
768
—
—
—
0
6
83
770
—
Routine general health check-up of other defined subpopulations
Z10.8 [45609907]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.12%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
76
708
—
—
—
—
—
—
Sprain and strain of finger(s)
S63.6 [45564454]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
5
80
748
Gas panel - Capillary blood
24337-8 [3022313]
—
8.3e-02
—
—
-1.0e+50
—
—
—
—
cases:7.23%
controls:6.69%
—
—
—
—
cases:0.00%
controls:2.06%
—
—
—
—
—
6
52
77
725
—
—
0
16
83
761
—
—
xylometazoline
R01AB06 [21605029]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:1.03%
—
—
—
—
—
—
—
—
—
—
—
0
8
83
769
—
—
—
—
—
Foot/toe symptom/complaint
L17 [2002000641]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.03%
—
—
—
—
—
—
—
0
8
83
768
—
pH of Venous blood
2746-6 [3012544]
-8.5e-02
—
—
—
—
8.9e-02
4.2e-01
cases:6.58%
controls:7.12%
—
—
—
—
—
—
—
—
cases:6.02%
controls:5.54%
cases:11.25%
controls:7.70%
5
51
71
665
—
—
—
—
5
43
78
733
9
58
71
695
Acute suppurative otitis media
H66.0 [45572040]
2.4e-01
—
-1.0e+50
—
—
7.3e-01
7.9e-01
cases:14.47%
controls:11.73%
—
—
cases:0.00%
controls:0.77%
—
—
—
—
cases:7.23%
controls:3.61%
cases:11.25%
controls:5.44%
11
84
65
632
—
0
6
83
771
—
—
6
28
77
748
9
41
71
712
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
5.1e-01
—
—
—
—
—
—
cases:6.58%
controls:4.05%
—
—
—
—
—
—
—
—
—
—
—
—
5
29
71
687
—
—
—
—
—
—
Complement C4 [Mass/volume] in Serum or Plasma
4498-2 [3017766]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.98%
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
—
—
—
0
7
76
709
0
5
83
772
—
—
—
—
—
pH of Serum or Plasma
2753-2 [3018418]
—
1.3e+00
-1.0e+50
—
—
—
2.5e-01
—
—
cases:7.23%
controls:2.06%
cases:0.00%
controls:0.90%
—
—
—
—
—
—
cases:6.25%
controls:4.91%
—
6
16
77
761
0
7
83
770
—
—
—
5
37
75
716
Intravenous
ZX120 [2001311495]
-1.0e+50
-1.0e+50
-1.0e+50
—
—
—
—
cases:0.00%
controls:1.96%
cases:0.00%
controls:1.67%
cases:0.00%
controls:0.77%
—
—
—
—
—
—
—
—
0
14
76
702
0
13
83
764
0
6
83
771
—
—
—
—
Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
75002-6 [44816893]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.80%
—
—
—
—
—
—
0
6
80
747
Cough
R05 [45606792]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.16%
—
—
—
—
—
—
—
0
9
83
767
—
CD4 cells/Lymphocytes in Specimen
80223-1 [21494815]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:1.68%
cases:0.00%
controls:0.90%
—
—
—
—
—
—
—
—
—
—
0
12
76
704
0
7
83
770
—
—
—
—
—
Intermittent exotropia
H50.31 [2000502353]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.99%
—
—
—
—
—
—
0
15
80
738
benzathine phenoxymethylpenicillin; oral
J01CE10 [21602850]
—
—
—
—
—
-1.0e+50
-7.6e-01
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:3.61%
cases:6.25%
controls:12.48%
—
—
—
—
—
0
28
83
748
5
94
75
659
Implantation of vascular injection port
TPX10 [2001309608]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.84%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
76
710
—
—
—
—
—
—
Person consulting for explanation of investigation findings
Z71.2 [45552100]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
—
—
—
—
0
5
83
772
—
—
—
—
—
amlodipine; oral
C08CA01 [21601747]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.77%
cases:0.00%
controls:1.59%
—
—
—
—
—
0
6
83
770
0
12
80
741
chlorphenamine, combinations
R06AB54 [21603468]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:1.40%
cases:0.00%
controls:0.64%
—
—
—
—
—
—
cases:0.00%
controls:0.90%
—
—
0
10
76
706
0
5
83
772
—
—
—
0
7
83
769
—
Dental caries
K02 [45552906]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.98%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
76
709
—
—
—
—
—
—
saccharomyces boulardii; oral
A07FA02 [21600670]
—
—
—
—
—
—
7.5e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.25%
controls:3.05%
—
—
—
—
—
—
5
23
75
730
Persistent ostium secundum
Q21.10 [2000503270]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:1.03%
—
—
—
—
—
—
—
—
—
—
—
0
8
83
769
—
—
—
—
—
Child and Adolescent Psychiatry
OMOP4821986 [45756756]
9.3e-01
6.3e-01
—
—
—
8.6e-01
5.8e-01
cases:14.47%
controls:6.28%
cases:7.23%
controls:3.99%
—
—
—
—
—
—
cases:10.84%
controls:4.90%
cases:16.25%
controls:9.83%
11
45
65
671
6
31
77
746
—
—
—
9
38
74
738
13
74
67
679
paracetamol, combinations excl. psycholeptics
N02BE51 [21604348]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.84%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
76
710
—
—
—
—
—
—
betamethasone
D07AC01 [21602120]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.98%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
76
709
—
—
—
—
—
—
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
—
—
-1.0e+50
—
-1.0e+50
—
-1.0e+50
—
—
—
—
cases:0.00%
controls:0.77%
—
—
cases:0.00%
controls:0.90%
—
—
cases:0.00%
controls:2.26%
—
—
0
6
83
771
—
0
7
83
770
—
0
17
80
736
Erythrocytes [Presence] in Urine
33051-4 [3045424]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
5
80
748
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
—
—
-1.0e+50
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.77%
—
—
—
—
—
—
—
—
—
—
0
6
83
771
—
—
—
—
Provision of consultation response
SPAT1285 [2001700386]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.98%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.80%
0
7
76
709
—
—
—
—
—
0
6
80
747
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
-3.4e-01
2.5e-01
—
—
—
-1.8e-01
4.6e-01
cases:10.53%
controls:14.25%
cases:14.46%
controls:11.58%
—
—
—
—
—
—
cases:7.23%
controls:8.51%
cases:23.75%
controls:16.47%
8
102
68
614
12
90
71
687
—
—
—
6
66
77
710
19
124
61
629
chlorhexidine
S02AA09 [21605155]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.29%
—
—
—
—
—
—
—
0
10
83
766
—
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
-3.0e-01
-6.0e-01
—
-1.0e+50
-1.0e+50
-8.8e-02
-3.4e-01
cases:14.47%
controls:18.58%
cases:9.64%
controls:16.22%
—
—
cases:0.00%
controls:1.03%
cases:0.00%
controls:3.86%
cases:10.84%
controls:11.73%
cases:18.75%
controls:24.57%
11
133
65
583
8
126
75
651
—
0
8
83
769
0
30
83
747
9
91
74
685
15
185
65
568
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
76
707
—
—
—
—
—
—
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:1.26%
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
—
—
—
0
9
76
707
0
5
83
772
—
—
—
—
—
Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
cases:0.00%
controls:0.77%
—
—
—
0
5
83
772
—
—
—
0
6
83
770
—
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
5.5e-01
—
-1.0e+50
—
—
-1.0e+50
6.8e-01
cases:6.58%
controls:3.91%
—
—
cases:0.00%
controls:0.64%
—
—
—
—
cases:0.00%
controls:2.06%
cases:8.75%
controls:4.65%
5
28
71
688
—
0
5
83
772
—
—
0
16
83
760
7
35
73
718
Acute pharyngitis, unspecified
J02.9 [45538472]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:1.12%
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.16%
—
—
0
8
76
708
—
—
—
—
0
9
83
767
—
triamcinolone and antiseptics
D07BB03 [21602150]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.29%
—
—
—
—
—
—
—
0
10
83
766
—
dexchlorpheniramine, combinations
R06AB52 [21603467]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.84%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
76
710
—
—
—
—
—
—
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
-3.6e-01
1.1e-01
3.2e-03
—
9.0e-02
4.7e-01
4.8e-01
cases:17.11%
controls:22.77%
cases:22.89%
controls:20.98%
cases:7.23%
controls:7.21%
—
—
cases:6.02%
controls:5.53%
cases:22.89%
controls:15.59%
cases:36.25%
controls:26.03%
13
163
63
553
19
163
64
614
6
56
77
721
—
5
43
78
734
19
121
64
655
29
196
51
557
Hand/finger symptom/complaint
L12 [2002000636]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:3.59%
—
—
—
—
—
—
0
27
80
726
Bile acid [Moles/volume] in Serum --fasting
35562-8 [3034274]
—
—
—
—
-1.0e+50
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.64%
cases:0.00%
controls:1.29%
cases:0.00%
controls:1.73%
—
—
—
—
0
5
83
772
0
10
83
766
0
13
80
740
carbamide
D02AE01 [21601975]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.98%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
76
709
—
—
—
—
—
—
Balanoposthitis
N48.1 [45567850]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.46%
—
—
—
—
—
—
0
11
80
742
Ear microscopy
UDC00 [2001301558]
—
-1.0e+50
—
—
—
—
1.2e+00
—
—
cases:0.00%
controls:1.80%
—
—
—
—
—
—
—
—
cases:6.25%
controls:1.99%
—
0
14
83
763
—
—
—
—
5
15
75
738
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
K40.9 [45543307]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
—
—
—
—
0
5
83
772
—
—
—
—
—
Lutropin [Units/volume] in Serum or Plasma
10501-5 [3009214]
—
—
—
—
—
—
1.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:11.25%
controls:3.19%
—
—
—
—
—
—
9
24
71
729
Preventive oral health care, extensive
SCA03 [2001310304]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.90%
—
—
—
—
—
—
—
—
—
—
—
0
7
83
770
—
—
—
—
—
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
-3.1e-01
1.6e-01
-3.5e-02
—
-4.4e-03
4.1e-01
3.4e-01
cases:18.42%
controls:23.60%
cases:25.30%
controls:22.39%
cases:7.23%
controls:7.46%
—
—
cases:6.02%
controls:6.05%
cases:24.10%
controls:17.40%
cases:40.00%
controls:32.14%
14
169
62
547
21
174
62
603
6
58
77
719
—
5
47
78
730
20
135
63
641
32
242
48
511
Impetigo
L01 [45548179]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.80%
—
—
—
—
—
—
0
6
80
747
losartan; oral
C09CA01 [21601824]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.06%
—
—
—
—
—
—
0
8
80
745
Corticotropin [Mass/volume] in Plasma
2141-0 [3035637]
—
—
—
—
—
—
1.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.25%
controls:1.59%
—
—
—
—
—
—
5
12
75
741
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 [3043849]
—
—
—
—
-1.0e+50
—
-1.0e+50
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.90%
—
—
cases:0.00%
controls:2.26%
—
—
—
—
0
7
83
770
—
0
17
80
736
Other administrative function
SPAT1281 [2001700382]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.68%
—
—
—
—
—
—
—
—
—
—
—
—
0
12
76
704
—
—
—
—
—
—
pH of Urine
2756-5 [3015736]
8.4e-01
—
—
—
—
—
—
cases:6.58%
controls:2.93%
—
—
—
—
—
—
—
—
—
—
—
—
5
21
71
695
—
—
—
—
—
—
lymecycline; oral, parenteral
J01AA04 [21602802]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:2.12%
—
—
—
—
—
—
0
16
80
737
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
—
—
-1.0e+50
—
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.03%
—
—
cases:0.00%
controls:1.16%
—
—
—
—
—
—
0
8
83
769
—
0
9
83
768
—
—
doxylamine, combinations
R06AA59 [40254475]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.84%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
76
710
—
—
—
—
—
—
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
—
—
—
—
—
1.1e-01
5.6e-01
—
—
—
—
—
—
—
—
—
—
cases:6.02%
controls:5.41%
cases:12.50%
controls:7.57%
—
—
—
—
—
5
42
78
734
10
57
70
696
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
117 [2001600117]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
76
711
—
—
—
—
—
—
Cholangitis
K83.0 [45552955]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.93%
—
—
—
—
—
—
0
7
80
746
Speech therapy
Z50.5 [45547321]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.77%
—
—
—
—
—
—
—
—
—
—
—
0
6
83
771
—
—
—
—
—
Periodic health check-up of children and adolescents
SPAT1315 [2001700416]
-3.0e-01
-1.7e-01
—
—
-1.0e+50
-2.9e-02
-2.1e-01
cases:25.00%
controls:31.01%
cases:14.46%
controls:16.73%
—
—
—
—
cases:0.00%
controls:1.67%
cases:14.46%
controls:14.82%
cases:23.75%
controls:27.76%
19
222
57
494
12
130
71
647
—
—
0
13
83
764
12
115
71
661
19
209
61
544
General Practice
1 [38004446]
—
—
-1.0e+50
—
-1.0e+50
—
-3.0e-01
—
—
—
—
cases:0.00%
controls:0.77%
—
—
cases:0.00%
controls:0.77%
—
—
cases:6.25%
controls:8.23%
—
—
0
6
83
771
—
0
6
83
771
—
5
62
75
691
Unequal limb length (acquired)
M21.7 [45548352]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.80%
—
—
—
—
—
—
0
6
80
747
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 [3019250]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:2.52%
—
—
—
—
—
—
0
19
80
734
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
-4.2e-01
4.5e-02
—
—
—
-2.1e-01
3.8e-01
cases:9.21%
controls:13.41%
cases:12.05%
controls:11.58%
—
—
—
—
—
—
cases:7.23%
controls:8.76%
cases:22.50%
controls:16.60%
7
96
69
620
10
90
73
687
—
—
—
6
68
77
708
18
125
62
628
insulin lispro; parenteral
A10AC04 [21600726]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:1.54%
cases:0.00%
controls:0.90%
—
—
—
—
—
—
cases:0.00%
controls:1.68%
cases:0.00%
controls:7.57%
0
11
76
705
0
7
83
770
—
—
—
0
13
83
763
0
57
80
696
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
—
5.0e-01
-1.0e+50
—
-1.0e+50
—
—
—
—
cases:7.23%
controls:4.50%
cases:0.00%
controls:1.16%
—
—
cases:0.00%
controls:1.03%
—
—
—
—
—
6
35
77
742
0
9
83
768
—
0
8
83
769
—
—
Consultation of another employee
SPAT1260 [2001700361]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:1.12%
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
—
—
—
0
8
76
708
0
5
83
772
—
—
—
—
—
Examination for period of rapid growth in childhood
Z00.2 [45595477]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
76
711
—
—
—
—
—
—
Parainfluenza type 4 nucleic acid detection
810871000000102 [44806118]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.77%
—
—
—
—
—
—
—
—
—
—
—
0
6
83
771
—
—
—
—
—
combinations of corticosteroids
D07AB30 [21602118]
-1.1e-01
—
—
—
—
-1.0e+50
3.4e-01
cases:6.58%
controls:7.26%
—
—
—
—
—
—
—
—
cases:0.00%
controls:3.35%
cases:10.00%
controls:7.30%
5
52
71
664
—
—
—
—
0
26
83
750
8
55
72
698
Dysuria
R30.0 [45592416]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.80%
—
—
—
—
—
—
0
6
80
747
Other fall from one level to another
W17 [45756255]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.33%
—
—
—
—
—
—
0
10
80
743
promethazine, combinations
R06AD52 [21603489]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:1.40%
cases:0.00%
controls:0.64%
—
—
—
—
—
—
cases:0.00%
controls:0.90%
—
—
0
10
76
706
0
5
83
772
—
—
—
0
7
83
769
—
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
3.8e-01
5.0e-01
-1.0e+50
—
-1.0e+50
—
6.8e-02
cases:6.58%
controls:4.61%
cases:7.23%
controls:4.50%
cases:0.00%
controls:0.77%
—
—
cases:0.00%
controls:0.77%
—
—
cases:7.50%
controls:7.04%
5
33
71
683
6
35
77
742
0
6
83
771
—
0
6
83
771
—
6
53
74
700
Lipid panel - Serum or Plasma
100898-6 [1761868]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.46%
—
—
—
—
—
—
0
11
80
742

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
37
32
15.15
37.57
6.4
6.2
2.30
2.55
ug/l
0.15
37
32
38
142
3.27
8.22
2.8
2.7
3.45
5.72
u/l
1.23
22
79
24
66
4.15
8.13
1.1
1.9
20.25
18.52
ng/l
0.28
24
66
37
143
3.13
7.52
2.9
2.7
5.26
7.95
iu/l
1.09
24
92
112
769
2.96
7.37
4.5
4.0
33.15
36.48
mmol/mol
8.39
112
739
43
186
2.86
7.13
2.5
3.0
288.86
329.91
nmol/l
0.80
43
181
13
18
7.81
6.07
1.0
1.0
—
—
—
0
0
7
8
9.11
3.81
1.3
1.5
74.00
74.38
%
—
7
8
7
8
9.11
3.81
1.3
1.5
551.43
434.88
mu/l
—
7
8
128
1065
2.64
3.81
5.6
4.9
1.92
1.94
mu/l
0.08
128
1017
6
7
8.87
3.29
1.0
1.1
—
—
—
0
0
46
286
1.89
2.99
2.3
1.6
106.24
95.08
pmol/l
0.83
21
140
8
18
4.64
2.84
1.9
2.3
—
—
—
0
0
9
23
4.10
2.82
2.0
2.4
21.88
12.93
umol/l
—
9
23
10
31
3.39
2.57
4.3
5.3
18.30
22.81
umol/l
—
10
31
83
636
1.71
2.56
12.8
12.8
—
—
—
0
0
39
251
1.76
2.21
4.2
4.5
7.38
7.39
ph
0.54
28
176
42
277
1.72
2.18
4.1
3.2
1.02
1.02
kg/l
0.59
31
183
42
278
1.72
2.15
1.4
1.3
—
—
—
0
0
28
165
1.86
2.10
2.8
5.6
0.21
0.21
g/l
0.22
28
158
10
38
2.75
2.05
1.4
1.2
—
—
—
0
0
8
183
0.40
1.99
2.3
2.0
—
—
—
0
0
10
39
2.68
1.98
1.4
1.2
0.46
0.42
g/l
—
10
29
10
39
2.68
1.98
1.4
1.2
6.57
6.26
g/l
—
10
31
10
39
2.68
1.98
1.4
1.2
1.86
2.05
g/l
—
10
32
26
153
1.85
1.96
3.5
2.0
7.93
11.65
nmol/l
1.80
26
140
103
871
1.62
1.88
13.8
14.6
3.67
3.54
e9/l
0.27
88
721
29
182
1.74
1.78
3.1
3.7
2.55
2.53
g/l
0.06
29
177
134
1227
2.12
1.74
12.6
8.9
—
—
—
0
0
22
129
1.83
1.68
28.4
16.6
106.14
105.47
mmol/l
0.25
22
129
15
78
2.03
1.61
26.4
15.1
6.04
5.33
kpa
0.94
15
73
15
78
2.03
1.61
26.5
15.0
0.17
-0.34
mmol/l
0.13
15
66
15
78
2.03
1.61
26.4
15.1
13.82
15.42
kpa
0.40
15
73
72
575
1.50
1.61
1.9
2.1
0.53
4.20
u/ml
—
10
106
97
825
1.52
1.58
11.3
12.2
0.04
0.04
e9/l
0.36
82
682
41
292
1.56
1.54
8.5
4.9
1.16
1.11
inr
0.25
28
240
99
848
1.52
1.54
13.1
13.2
0.22
0.22
e9/l
0.01
87
722
97
829
1.51
1.52
10.9
12.1
0.61
0.55
e9/l
1.16
82
686
10
45
2.31
1.50
1.4
2.3
—
6.67
—
0
7
9
39
2.39
1.46
2.4
4.1
2.72
2.21
mmol/l
—
9
39
5
17
3.01
1.37
1.6
2.5
—
—
—
0
0
33
452
0.65
1.34
2.2
2.1
—
—
—
0
0
98
851
1.46
1.32
11.1
12.0
2.48
2.31
e9/l
0.54
85
733
32
224
1.55
1.29
7.2
4.6
—
—
—
0
0
36
259
1.52
1.29
2.2
3.3
55.31
58.76
u/l
0.28
36
245
26
174
1.60
1.26
2.3
2.2
18.57
24.50
ng/l
0.21
12
75
11
57
2.01
1.20
17.8
19.6
0.75
0.68
%
0.20
11
57
12
65
1.92
1.17
1.8
1.8
—
—
—
0
0
65
533
1.40
1.16
9.9
10.6
—
—
—
0
0
11
59
1.93
1.10
17.8
19.1
0.97
1.06
%
0.23
11
59
118
1261
0.67
1.06
19.7
13.1
26.40
24.42
mg/l
0.27
90
915
16
99
1.69
1.05
1.4
1.3
396.25
74444908.62
pmol/l
0.49
16
90
5
22
2.32
1.04
1.6
1.7
—
—
—
0
0
10
53
1.95
1.04
1.6
1.2
—
—
—
0
0
25
175
1.52
1.01
1.5
1.7
266.67
354.29
titre
—
6
28
19
275
0.64
0.98
1.9
1.9
—
—
—
0
0
14
86
1.69
0.95
2.8
9.7
117.56
272.64
mg/l
—
9
74
21
144
1.54
0.94
24.0
16.0
1.47
1.39
mmol/l
0.10
21
138
26
187
1.47
0.93
1.3
1.4
—
118.57
—
0
7
11
63
1.81
0.93
17.8
18.0
93.64
94.32
%
0.09
11
63
12
72
1.73
0.88
1.0
1.1
—
—
—
0
0
31
400
0.71
0.88
2.5
2.3
—
—
—
0
0
17
113
1.57
0.87
2.4
2.1
—
—
—
0
0
19
132
1.51
0.81
1.7
1.7
—
—
—
0
0
6
33
1.85
0.80
1.5
1.6
—
—
—
0
0
9
56
1.65
0.74
8.6
4.3
43.36
38.54
%
—
9
56
5
25
2.03
0.73
1.8
2.1
—
—
—
0
0
5
26
1.95
0.71
2.2
5.5
7.39
7.39
ph
—
5
26
9
58
1.59
0.71
8.6
3.9
32.56
28.40
%
—
9
58
7
42
1.70
0.69
4.7
5.8
—
—
—
0
0
5
27
1.88
0.69
2.0
1.7
—
—
—
0
0
5
29
1.75
0.64
1.8
1.4
186.00
279.69
pmol/l
—
5
29
8
49
1.67
0.63
2.8
2.3
—
—
—
0
0
8
49
1.67
0.63
2.8
2.3
—
—
—
0
0
8
49
1.67
0.63
2.8
2.3
—
—
—
0
0
8
49
1.67
0.63
2.8
2.3
—
—
—
0
0
32
257
1.31
0.62
3.8
2.6
—
—
—
0
0
5
30
1.69
0.62
1.4
1.3
0.09
0.36
nmol/l
—
5
24
64
563
1.24
0.61
3.0
1.9
1.43
1.56
g/l
0.40
34
290
10
64
1.60
0.60
8.2
4.0
12.40
13.88
%
—
10
64
20
150
1.39
0.60
1.3
1.3
23.08
13.13
iu/ml
—
6
31
5
88
0.55
0.58
1.4
1.2
—
—
—
0
0
37
307
1.27
0.57
2.3
4.0
45.57
108.37
ug/g
1.53
26
250
8
55
1.48
0.57
1.1
2.2
—
—
—
0
0
9
61
1.51
0.55
8.4
4.1
9.89
9.07
%
—
9
61
9
61
1.51
0.55
8.4
4.1
74.78
70.95
%
—
9
61
130
1247
1.39
0.55
24.2
19.0
335.76
335.60
g/l
0.07
130
1242
19
144
1.37
0.54
2.2
2.0
—
—
—
0
0
42
358
1.24
0.52
22.6
15.2
24.67
24.98
mmol/l
0.30
42
358
58
515
1.21
0.49
4.6
3.4
6.45
6.29
ph
0.54
32
238
21
166
1.31
0.46
4.2
3.3
1448.77
842.47
ng/l
0.34
13
91
8
59
1.38
0.41
2.6
6.5
—
—
—
0
0
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
0
17
0.00
0.41
0.0
2.1
—
—
—
0
0
37
320
1.21
0.40
12.3
12.4
—
—
—
0
0
65
593
1.17
0.39
4.8
3.7
0.00
0.00
estimate
—
5
105
34
294
1.20
0.37
3.9
3.9
7.64
5.95
e6/l
0.28
29
263
28
327
0.82
0.37
1.8
1.9
—
—
—
0
0
65
596
1.16
0.36
4.8
3.7
0.00
0.00
estimate
—
6
100
6
42
1.45
0.36
1.0
1.0
0.95
0.86
g/l
—
6
42
6
42
1.45
0.36
1.0
1.0
1.40
1.51
g/l
—
6
42
38
430
0.84
0.36
1.4
1.7
—
—
—
0
0
59
538
1.16
0.35
2.5
2.4
—
—
—
0
0
18
146
1.27
0.34
4.5
6.4
67.37
61.98
e9/l
0.34
12
99
65
599
1.15
0.33
4.8
3.8
0.00
0.00
estimate
—
6
99
23
194
1.22
0.32
5.4
9.2
1.49
1.40
%
0.27
23
188
11
84
1.33
0.31
1.0
1.0
—
—
—
0
0
24
278
0.84
0.29
6.4
4.1
1.25
1.47
e6/l
0.12
13
148
8
62
1.31
0.28
1.1
1.3
—
—
—
0
0
13
105
1.26
0.26
1.9
1.4
—
—
—
0
0
38
343
1.15
0.25
4.8
5.2
6.41
8.43
mmol/l
1.49
32
325
33
367
0.87
0.25
4.0
3.8
—
—
—
0
0
6
82
0.72
0.25
3.7
9.1
—
0.03
—
0
30
5
39
1.29
0.23
2.0
2.5
—
—
—
0
0
37
336
1.14
0.23
15.4
12.0
7.36
7.37
ph
1.00
32
223
5
41
1.23
0.22
2.4
6.0
—
—
—
0
0
5
41
1.23
0.22
2.0
2.2
25.34
10.64
ug/l
—
5
35
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
0.46
—
0
10
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
3.8
—
44.70
—
0
10
0
10
0.00
0.21
0.0
7.6
—
6.90
—
0
10
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
3.8
—
32.50
—
0
12
16
136
1.20
0.21
1.1
1.3
0.76
5.35
u/ml
—
5
45
0
13
0.00
0.21
0.0
1.0
—
159.20
—
0
13
0
14
0.00
0.20
0.0
2.9
—
—
—
0
0
6
49
1.23
0.20
1.0
1.0
—
—
—
0
0
7
62
1.14
0.17
1.4
1.2
—
—
—
0
0
83
798
1.09
0.17
15.5
14.1
0.00
0.00
e9/l
0.50
62
602
5
67
0.74
0.17
1.6
2.9
53.56
49.87
%
—
5
67
34
313
1.11
0.17
15.4
11.6
23.29
23.67
mmol/l
0.51
34
313
31
285
1.11
0.16
4.9
3.8
0.00
0.00
estimate
—
5
99
24
217
1.13
0.16
2.6
5.9
2.98
2.45
mg/l
0.14
17
159
36
334
1.10
0.15
15.5
11.9
0.44
0.96
mmol/l
0.47
29
270
9
79
1.15
0.15
1.9
2.2
—
—
—
0
0
14
159
0.87
0.14
1.1
1.3
5.79
3.39
u/ml
—
9
121
14
124
1.14
0.11
3.0
1.4
—
—
—
0
0
27
290
0.92
0.11
18.0
9.5
—
—
—
0
0
31
330
0.92
0.11
17.6
9.5
5.24
5.02
kpa
0.95
31
322
16
146
1.11
0.08
1.8
2.5
—
—
—
0
0
5
61
0.81
0.08
2.8
5.7
3.30
3.27
mmol/l
—
5
61
5
63
0.79
0.08
1.2
1.2
—
—
—
0
0
7
63
1.12
0.08
1.4
1.2
—
—
—
0
0
74
721
1.05
0.08
14.8
8.1
5.79
6.17
mmol/l
0.90
74
673
7
66
1.06
0.08
1.3
1.3
—
—
—
0
0
6
72
0.83
0.08
49.0
15.3
0.58
0.58
%
—
6
72
45
467
0.95
0.07
4.2
3.7
—
—
estimate
—
0
0
29
305
0.94
0.07
1.7
2.2
—
—
—
0
0
13
141
0.91
0.05
3.8
2.9
4.74
3.84
e9/l
0.64
13
131
14
151
0.92
0.05
1.0
1.2
4.88
3.34
u/ml
—
9
110
14
150
0.93
0.04
4.1
1.8
—
—
—
0
0
23
220
1.05
0.04
1.7
1.7
—
—
—
0
0
125
1242
1.04
0.02
17.0
12.0
54.06
59.42
umol/l
2.15
125
1222
11
103
1.07
0.02
1.2
1.3
—
—
—
0
0
15
143
1.05
0.01
3.9
1.8
—
—
—
0
0
14
146
0.95
0.00
1.0
1.3
2.32
1.16
u/ml
—
8
109
17
176
0.96
0.00
2.1
1.9
—
—
—
0
0
52
526
0.98
0.00
7.4
5.9
58.76
35.27
e6/l
0.29
36
354
15
149
1.01
0.00
3.9
1.8
—
—
—
0
0
15
149
1.01
0.00
3.9
1.8
—
—
—
0
0
15
151
0.99
0.00
3.9
1.8
—
—
—
0
0
28
276
1.02
0.00
2.9
1.7
—
—
—
0
0
42
421
1.00
0.00
5.8
4.7
0.13
0.20
e6/l
0.27
31
302
46
461
1.00
0.00
5.9
4.8
10.91
23.06
e6/l
1.13
35
343
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
3.88
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
1989.00
—
0
5
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
65.80
—
0
5
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
4.7
—
1.38
—
0
6
6
65
0.92
-0.00
2.5
5.8
333.33
358.18
mg/l
—
6
65
7
72
0.97
-0.00
1.1
1.2
—
—
—
0
0
5
50
1.00
-0.00
3.2
7.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
4.9
—
4.57
—
0
9
0
6
0.00
-0.00
0.0
1.8
—
3.87
—
0
6
0
6
0.00
-0.00
0.0
12.7
—
36.17
—
0
6
7
71
0.99
-0.00
2.9
1.6
0.89
0.87
ug/l
—
7
63
26
260
1.00
-0.00
2.6
6.9
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: E4_SHORT_STATURE_STARTING_BEFORE_BIRTH – Short stature starting before birth

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).